Screening Clinical Trials for Prostate Cancer

Clinical trials are research studies that involve people. The clinical trials on this list are for prostate cancer screening. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-2 of 2
  • Fluorine F 18 DCFPyL PET / CT in Detecting High-Grade Prostate Cancer in Participants with Elevated PSA

    This phase II trial studies how well fluorine F 18 DCFPyL positron emission tomography / computed tomography (PET / CT) imaging works in detecting high-grade prostate cancer in participants with elevated prostate-specific antigen (PSA) levels. A PET scan uses radioactive material, also known as a radiotracer, injected into the blood to show the internal workings of the body. A CT scan uses x-rays and a computer to produce a 3-dimensional image of the body. Fluorine F 18 DCFPyL is a radioactive tracer, which when used with combined PET / CT imaging, may help doctors more accurately locate areas of high grade prostate cancer in participants with elevated PSA.
    Location: Johns Hopkins University / Sidney Kimmel Cancer Center, Baltimore, Maryland

  • Informed Decision Making Intervention in Screening for Prostate Cancer in High-Risk African American Participants

    This clinical trial studies informed decision making intervention in screening for prostate cancer in high-risk African American participants. Using decision aids such as culturally sensitive written material, verbal information, and videos to educate patients about screening may increase patient participation and increase confidence in participants' decisions. Raising awareness about prostate cancer in the communities may increase the participants' willingness to be screened for prostate cancer once they have learned about it.
    Location: Case Comprehensive Cancer Center, Cleveland, Ohio